AVITA Medical (FRA:51KB) Other Long-Term Liabilities : €2.88 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Other Long-Term Liabilities?

AVITA Medical's other long-term liabilities for the quarter that ended in Mar. 2025 was €2.88 Mil.

AVITA Medical's quarterly other long-term liabilities increased from Sep. 2024 (€2.69 Mil) to Dec. 2024 (€6.38 Mil) but then declined from Dec. 2024 (€6.38 Mil) to Mar. 2025 (€2.88 Mil).

AVITA Medical's annual other long-term liabilities increased from Dec. 2022 (€0.53 Mil) to Dec. 2023 (€3.53 Mil) and increased from Dec. 2023 (€3.53 Mil) to Dec. 2024 (€6.38 Mil).

AVITA Medical Other Long-Term Liabilities Historical Data

The historical data trend for AVITA Medical's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Other Long-Term Liabilities Chart

AVITA Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

0.42

0.53

3.53

6.38

AVITA Medical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															4.47	2.20	2.69	6.38	2.88

AVITA Medical Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

AVITA Medical Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (FRA:51KB) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

RCEL:USA AVHHL:USA AVH:Australia

Address

28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

AVITA Medical Headlines

No Headlines